BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28882024)

  • 1. Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients.
    Lee M; Kim M; Park JS; Lee S; You J; Ahn CW; Kim KR; Kang S
    Korean J Intern Med; 2019 Sep; 34(5):1068-1077. PubMed ID: 28882024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.
    Wewer Albrechtsen NJ; Junker AE; Christensen M; Hædersdal S; Wibrand F; Lund AM; Galsgaard KD; Holst JJ; Knop FK; Vilsbøll T
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G91-G96. PubMed ID: 28971838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Moh Moh MA; Jung CH; Lee B; Choi D; Kim BY; Kim CH; Kang SK; Mok JO
    Diab Vasc Dis Res; 2019 Mar; 16(2):186-195. PubMed ID: 30428692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial.
    Jakubowicz D; Wainstein J; Ahren B; Landau Z; Bar-Dayan Y; Froy O
    Diabetes Care; 2015 Oct; 38(10):1820-6. PubMed ID: 26220945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects.
    Demant M; Bagger JI; Suppli MP; Lund A; Gyldenløve M; Hansen KB; Hare KJ; Christensen M; Sonne DP; Holst JJ; Vilsbøll T; Knop FK
    Metab Syndr Relat Disord; 2018 Dec; 16(10):530-536. PubMed ID: 30325692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Study of Correlation of Glucagon-Insulin Ratio with Hba1c in Diabetic Patients in a Tertiary Care Hospital.
    Kumar R; Srivastava S; Jain G; Pahadiya H
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes.
    Lugari R; Dei Cas A; Ugolotti D; Finardi L; Barilli AL; Ognibene C; Luciani A; Zandomeneghi R; Gnudi A
    Horm Metab Res; 2002 Mar; 34(3):150-4. PubMed ID: 11972305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subgroup analysis of proinsulin and insulin levels reveals novel correlations to metabolic indicators of type 2 diabetes.
    Li T; Quan H; Zhang H; Lin L; Lin L; Ou Q; Chen K
    Aging (Albany NY); 2020 Jun; 12(11):10715-10735. PubMed ID: 32532930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Starting bedtime glargine versus NPH insulin in poorly controlled type 2 diabetic patients with various hyperglycemia types (fasting type or postprandial type).
    Vähätalo MA; Viikari J; Rönnemaa T
    Acta Diabetol; 2014 Apr; 51(2):233-8. PubMed ID: 23880900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of glycated hemoglobin, and fasting and postprandial hyperglycemia in type 2 diabetes mellitus patients in Malaysia.
    Lim LL; Brnabic AJ; Chan SP; Ibrahim L; Paramasivam SS; Ratnasingam J; Vethakkan SR; Tan ATB
    J Diabetes Investig; 2017 Jul; 8(4):453-461. PubMed ID: 27863088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.
    Calanna S; Scicali R; Di Pino A; Knop FK; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2014 Aug; 51(4):567-75. PubMed ID: 24442427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetes.
    Sjöstrand M; Iqbal N; Lu J; Hirshberg B
    Diabetes Res Clin Pract; 2014 Aug; 105(2):185-91. PubMed ID: 24947443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes.
    Shim WS; Kim SK; Kim HJ; Kang ES; Ahn CW; Lim SK; Lee HC; Cha BS
    Eur J Endocrinol; 2006 Oct; 155(4):615-22. PubMed ID: 16990662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED HEMOGLOBIN A1C.
    Shaefer C; Reid T; Vlajnic A; Zhou R; DiGenio A
    Endocr Pract; 2015 Dec; 21(12):1323-32. PubMed ID: 26307902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes.
    Fredheim S; Andersen ML; Pörksen S; Nielsen LB; Pipper C; Hansen L; Holst JJ; Thomsen J; Johannesen J; Mortensen HB; Svensson J
    Diabetologia; 2015 Apr; 58(4):828-34. PubMed ID: 25541633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus.
    Bonde L; Vilsbøll T; Nielsen T; Bagger JI; Svare JA; Holst JJ; Larsen S; Knop FK
    Diabetes Obes Metab; 2013 Aug; 15(8):713-20. PubMed ID: 23406269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?
    Paul SK; Holman RR
    Diabet Med; 2017 Sep; 34(9):1284-1290. PubMed ID: 28477414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased glycemic variability and decrease of the postprandial glucose contribution to HbA1c in obese subjects across the glycemic continuum from normal glycemia to first time diagnosed diabetes.
    Fysekidis M; Cosson E; Banu I; Duteil R; Cyrille C; Valensi P
    Metabolism; 2014 Dec; 63(12):1553-61. PubMed ID: 25308444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.
    Kim JY; Michaliszyn SF; Nasr A; Lee S; Tfayli H; Hannon T; Hughan KS; Bacha F; Arslanian S
    Diabetes Care; 2016 Aug; 39(8):1431-9. PubMed ID: 27293201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.